FORA Capital’s Disc Medicine IRON Stock Holding History

FORA Capital’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,735	Closed	-$544K	–	515
2025 Q4	$544K	Buy	+6,735	New	+$569K	0.07%	284

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

FORA Capital's IRON Position: Q1 2026 in Review

FORA Capital sold out of Disc Medicine (IRON) in Q1 2026, closing a stake of 6,735 shares — an estimated $544K sold.

FORA Capital first reported a position in IRON in Q4 2025 and held it in 1 quarter. The position peaked at $544K in Q4 2025. 203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

FORA Capital reported no remaining Disc Medicine position as of Q1 2026 after selling out during the quarter.
FORA Capital sold 6,735 Disc Medicine shares in Q1 2026, an estimated $544K.
FORA Capital first reported a position in Disc Medicine in Q4 2025 and held it in 1 quarter.
FORA Capital's Disc Medicine position peaked at $544K in Q4 2025.
203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.